Anavex Life Sciences Corp (AVXL)

[makemydaze]

Could success in a Rett trial be an indication of possible success in Alzheimers? -

"Previous clinical tests of Anavex 2-73 for Alzheimer’s produced an attractive safety profile along with positive cognitive, anti-anxiety and anti-seizure effects. Since Alzheimer’s and Rett sydrome share many of the same symptoms, including cognitive impairment, anxiety and seizures, it seemed possible that the drug might have similarly positive results in the rare disease."

What is Retts Syndrome? -

"Rett syndrome is a non-inherited disease that mainly affects girls. The disease cannot be predicted, and it usually first appears between the ages of 6 and 18 months, at which point girls lose purposeful use of their hands, show distinctive hand movements and experience slowed brain and head growth, as well as problems with walking, seizures and intellectual disability."

How did Anavex become involved with Rett?

“Anavex heard about our Scout program, which helps drug companies study a compound’s potential for Rett sydrome at very low risk,” Steve Kaminsky, chief science officer of Rettsyndrome.org, tells DDNews. “They took a chance by giving the drug to our contract research organization, and it produced very positive results with a solid amount of clinical data.”

http://www.ddn-news.com/index.php?newsarticle=10542

It's just my opinion but I feel if Anavex 2-73 can improve the lives of these people with Rett Syndrome(considering the symptoms) then it will also be successful in other indications. JMO